Synthesis of Cetyl Myristoleate (CMO) Isomers for the Treatment of Osteoarthritis and Other Joint Inflammatory Diseases
Implementing Organization
Indian Institute of Chemical Technology (IICT)
Project Overview
Cetyl myristoleate (CMO) is the common name for hexadecyl cis-9- myristoleate. CMO is well known for its anti-arthritis properties. The main component of CMO is cis-9 myristoleic acid, and is being isolated from selective natural sources along with other fatty acids. CMO is being sold in the market for the treatment of different forms of arthritis, osteoarthritis, as well as many other forms of diseases.